Search the Newsreel

Archrock (AROC) Could Be 21% Undervalued On Strong Q2 Results And Higher Guidance

Patrick Burnett Sells 6,700 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock

Patrick Burnett, an insider at Arcutis Biotherapeutics (NASDAQ:ARQT), sold 6,700 shares of the company's stock for $174,736 on August 12th, reducing his direct stake by over 5%. This sale follows two earlier transactions in August where he sold an additional 9,255 shares. Despite the …

Marcus & Millichap arranges $3.9 million sale of 56,000 s/f 470 Pine St.

Marcus & Millichap successfully brokered the sale of 470 Pine St., a 56,000 square foot multi-tenant building in downtown Manchester, NH, for $3.9 million. The property, originally built in 1924 and converted from a mill to a school, is fully occupied by three educational …

Arcutis Biotherapeutics EVP, CMO Burnett sells $394,896 in stock By Investing.com

Patrick Burnett, EVP and CMO of Arcutis Biotherapeutics (NASDAQ:ARQT), sold shares worth $394,896 in two transactions on August 11 and 12, 2026, following the exercise of stock options. The company's shares have seen a 61.64% return over the past year, and recent Q2 2026 …

Arcadia Biosciences earnings missed by $1.53, revenue fell short of estimates

Could Arcus Biosciences (RCUS) and Summit Therapeutics (SMMT)’s Cancer Drug Partnership Create a New Treatment Standard?

On July 22, Arcus Biosciences, Inc. (NYSE:RCUS) and Summit Therapeutics Inc. (NASDAQ:SMMT) announced a major clinical trial collaboration to combine Arcus's casdatifan (an investigational HIF-2α inhibitor) with Summit's ivonescimab (an investigational PD-1/VEGF bispecific antibody). The study aims to evaluate the safety and efficacy of …

Arcus Biosciences (RCUS) Reported Q2 2026 Results, Is The Stock A Bargain?

Arcus Biosciences reported Q2 2026 results with $41 million in revenue and a $91 million net loss, along with new full-year revenue guidance. The stock has seen significant price returns (16.07% in 90 days, 24.35% YTD), and a current valuation suggests it is 24% …

Digimarc outlines go-to-market rebuild as Secure Gift Card pipeline grows over 30x to more than 31 retailers

Earnings Call Insights: Digimarc (DMRC) Q2 2026 MANAGEMENT VIEW * CEO Paul Carreiro framed the quarter around execution changes, saying Digimarc is “held back by commercial execution gap that is entirely fixable” and that “what was missing was leadership focus, structure and accountability to …

Barclays PLC (NHIC) trims Newhold Investment Corp II-A stake to 4.13% of shares

Barclays PLC has reported a reduction in its beneficial ownership of Newhold Investment Corp II-A common stock, now holding 4.13% of the class. This amounts to 863,817 shares, with the majority having sole voting and dispositive power. The filing indicates that Barclays' stake is …

Barclays PLC (PEN) discloses 2.34M-share beneficial stake in Penumbra Inc

Barclays PLC has reported a beneficial ownership of 2,342,118 shares of Penumbra Inc (PEN) common stock, representing 5.95% of the class as of June 30, 2026. The filing, a Schedule 13G, indicates that Barclays holds sole voting and dispositive power over 2,340,999 shares and …

Barclays PLC discloses 1.23M Axiom Intelligence (AXIN) shares on Schedule 13G

Barclays PLC has reported a beneficial ownership of 1,231,531 shares of Axiom Intelligence (AXIN) Class A common stock, representing a 5.97% stake. The filing indicates Barclays PLC has sole voting and dispositive power over 1,201,531 shares, and shared power over an additional 30,000 shares. …

Digimarc Reports Second Quarter 2026 Financial Results

Digimarc Corporation reported its second-quarter 2026 financial results, with total revenue decreasing to $7.4 million from $8.0 million in Q2 2025, primarily due to lower subscription revenue following contract expirations. Despite a net loss increase to $12.1 million, the company's CEO, Paul Carreiro, expressed …

Arcos Dorados Holdings (ARCO) Stock Still Looks Undervalued After A 73% Return

Digimarc (NASDAQ:DMRC) Releases Earnings Results, Beats Expectations By $0.25 EPS

Digimarc Q2 Results: Revenue down 7% YoY to $7.4 million

Here’s How Much You Would Have Made Owning ACM Research Stock In The Last 5 Years

ACM Research (NASDAQ: ACMR) has outperformed the market over the last five years, with an annualized return of 24.64%. An initial investment of $1000 in ACMR stock five years ago would now be worth $2,921.90. This demonstrates the significant impact of compounded returns on …

Barclays PLC (FWRD) discloses 7.84% stake in Forward Air on Schedule 13G

Barclays PLC has disclosed a 7.84% beneficial ownership stake in Forward Air Corp (FWRD) through a Schedule 13G filing. This represents 2,480,010 shares, with Barclays Bank PLC, Barclays Capital Inc, and Barclays Capital Securities Ltd identified as involved subsidiaries. The filing indicates that Barclays …

Earnings call transcript: Digimarc beats Q2 2026 estimates but shares fall

Digimarc (DMRC) reported a narrower-than-expected loss and slightly better revenue for Q2 2026, beating analyst estimates. However, shares fell due to ongoing pressure on recurring revenue from contract losses and delayed significant growth in its gift-card business until late 2026 and early 2027. The …

Archimedes Tech SPAC Partners II Reports Q2 2026 10-Q with Significant PIPE-Related Losses

Archimedes Tech SPAC Partners II reported a significant net loss of $135,048,119 for the first half of 2026, primarily due to a $100,000,000 PIPE subscription expense and a $37,942,000 adjustment in the fair value of a PIPE subscription derivative liability. This contrasts sharply with …

Antarctica Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

FactSet Research Systems Inc. Announces Quarterly Dividend of $1.16 (NYSE:FDS)

FactSet Research Systems Inc. (NYSE:FDS) has announced a quarterly dividend of $1.16 per share, maintaining its 27-year streak of dividend increases. The dividend will be paid on September 17th to shareholders of record on August 31st, representing an annualized dividend of $4.64 and a …

Archer Aviation (NYSE:ACHR) Shares Up 11.4% - Here's What Happened

DMRC Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares Fall 5.63% - ROIC Trend Report

Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com

This article reports on the filing of a Form 8K by Arcadia Biosciences Inc. on August 13. The company's stock symbol is RKDA, and its shares experienced a 9.60% increase. The brief announcement provides no further details about the content of the 8K filing.

Arcadia Biosciences: Q2 Earnings Snapshot

Digimarc earnings beat by $0.25, revenue topped estimates

Digimarc Corporation (DMRC) Releases Q2 2026 Earnings: Revenue Declines and Losses Widen

GH Research PLC (GHRS) director receives 2,202 options at $0.025 strike

GH Research PLC director Dermot John Hanley was granted 2,202 share options with an exercise price of $0.025 per share. These options vested immediately but are not exercisable until August 11, 2028, and will expire on August 11, 2033. Following this transaction, Hanley directly …

GH Research PLC (GHRS) director receives 2,202 fully vested share options

GH Research PLC director Duncan Moore was granted 2,202 fully vested share options on August 11, 2026, with an exercise price of $0.0250 per ordinary share and an expiration date of August 11, 2033. Although immediately vested, these options are not exercisable until August …

GH Research PLC (GHRS) grants 102,202 share options to director Michael Forer

GH Research PLC (GHRS) director Michael Forer received two grants of share options totaling 102,202 Ordinary Shares, both with an exercise price of $0.0250 per share and expiring on August 11, 2033. One grant of 2,202 options is immediately vested but not exercisable until …

Archimedes Tech SPAC III (ARCI) shows $280M in trust and Q2 2026 net income

Lam Research Plans Labs to Handle 50% More Experiments

Lam Research (NASDAQ: LRCX) announced plans to invest over $3 billion in its global R&D lab network across the U.S., Asia, and Europe over the next five years. This expansion aims to increase experiment capacity by more than 50% and further compress product development …

Archimedes Tech SPAC Partners III Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Archimedes Tech SPAC (ATII) details $1.2B Forge Nano deal and $135M loss

Archimedes Tech SPAC Partners II Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

UTSI Q4 2019 Earnings: Wider-than-Expected Loss of -$0.40 Per Share Raises Concerns - High Estimate Range